Paloma Partners’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-6,900
| Closed | -$408K | – | 1260 |
|
|
2024
Q2 | $408K | Buy |
+6,900
| New | +$432K | 0.01% | 823 |
|
|
2024
Q1 | – | Sell |
-16,400
| Closed | -$1.29M | – | 835 |
|
|
2023
Q4 | $1.29M | Buy |
16,400
+13,000
| +382% | +$925K | 0.05% | 362 |
|
|
2023
Q3 | $237K | Buy |
+3,400
| New | +$241K | 0.01% | 569 |
|
|
2023
Q2 | – | Sell |
-90,000
| Closed | -$6.69M | – | 790 |
|
|
2023
Q1 | $6.69M | Buy |
90,000
+68,800
| +325% | +$5.77M | 0.24% | 71 |
|
|
2022
Q4 | $1.98M | Buy |
21,200
+4,200
| +25% | +$405K | 0.09% | 223 |
|
|
2022
Q3 | $1.62M | Buy |
+17,000
| New | +$1.68M | 0.07% | 225 |
|
|
2022
Q2 | – | Sell |
-7,600
| Closed | -$769K | – | 1238 |
|
|
2022
Q1 | $769K | Buy |
+7,600
| New | +$798K | 0.02% | 539 |
|
|
2021
Q3 | – | Sell |
-210,800
| Closed | -$17.6M | – | 1250 |
|
|
2021
Q2 | $17.6M | Buy |
210,800
+187,600
| +809% | +$15.4M | 0.32% | 54 |
|
|
2021
Q1 | $1.75M | Buy |
+23,200
| New | +$1.69M | 0.04% | 460 |
|
|
2020
Q4 | – | Sell |
-59,600
| Closed | -$3.48M | – | 1747 |
|
|
2020
Q3 | $3.48M | Buy |
59,600
+28,800
| +94% | +$1.79M | 0.09% | 225 |
|
|
2020
Q2 | $2M | Buy |
+30,800
| New | +$1.94M | 0.03% | 628 |
|
|
2019
Q4 | – | Sell |
-52,100
| Closed | -$3.29M | – | 2212 |
|
|
2019
Q3 | $3.29M | Sell |
52,100
-8,400
| -14% | -$498K | 0.07% | 246 |
|
|
2019
Q2 | $3.3M | Sell |
60,500
-50,900
| -46% | -$2.74M | 0.06% | 272 |
|
|
2019
Q1 | $6.01M | Buy |
111,400
+96,300
| +638% | +$5.94M | 0.15% | 130 |
|
|
2018
Q4 | $989K | Sell |
15,100
-19,200
| -56% | -$1.43M | 0.03% | 458 |
|
|
2018
Q3 | $2.7M | Buy |
34,300
+22,400
| +188% | +$1.6M | 0.05% | 356 |
|
|
2018
Q2 | $766K | Sell |
11,900
-74,300
| -86% | -$4.9M | 0.01% | 833 |
|
|
2018
Q1 | $5.36M | Buy |
86,200
+53,100
| +160% | +$3.81M | 0.08% | 189 |
|
|
2017
Q4 | $2.4M | Buy |
33,100
+8,900
| +37% | +$647K | 0.03% | 586 |
|
|
2017
Q3 | $1.97M | Hold |
24,200
| – | – | 0.03% | 754 |
|
|
2017
Q2 | $1.95M | Sell |
24,200
-221,100
| -90% | -$17.5M | 0.02% | 777 |
|
|
2017
Q1 | $19.3M | Buy |
245,300
+195,300
| +391% | +$15.6M | 0.23% | 62 |
|
|
2016
Q4 | $3.95M | Buy |
50,000
+34,000
| +213% | +$2.75M | 0.04% | 336 |
|
|
2016
Q3 | $1.42M | Sell |
16,000
-16,000
| -50% | -$1.51M | 0.02% | 740 |
|
|
2016
Q2 | $3.06M | Hold |
32,000
| – | – | 0.03% | 457 |
|
|
2016
Q1 | $3.32M | Buy |
+32,000
| New | +$3.11M | 0.05% | 294 |
|
Other funds holding CVS
Paloma Partners's CVS Position: Q3 2024 in Review
Paloma Partners sold out of CVS Health (CVS) in Q3 2024, closing a stake of 15,700 shares — an estimated $927K sold.
Paloma Partners first reported a position in CVS in Q2 2013 and held it in 38 quarters. The position peaked at $43.8M in Q1 2019. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.
- Paloma Partners reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
- Paloma Partners sold 15,700 CVS Health shares in Q3 2024, an estimated $927K.
- Paloma Partners first reported a position in CVS Health in Q2 2013 and held it in 38 quarters.
- Paloma Partners's CVS Health position peaked at $43.8M in Q1 2019.
- 1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.
Based on Paloma Partners's 13F filing for Q3 2024, filed 14 Nov 2024.